In contrast, the drug BIRT377, which inhibits the high-affinity conformation of LFA-1 by blocking domain I in the β2 subunit, enhances NK cell infiltration into colorectal carcinoma and drives tumor regression in mice models (105). This evidence concerns the gene ITGAL and neoplasm.